4.7 Article

Variations in O-Glycosylation Patterns Influence Viral Pathogenicity, Infectivity, and Transmissibility in SARS-CoV-2 Variants

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Site specific N- and O-glycosylation mapping of the spike proteins of SARS-CoV-2 variants of concern

Asif Shajahan et al.

Summary: This study compares the glycosylation profiles of different variants of the SARS-CoV-2 virus and finds that the glycosylation sites on the spike protein remain highly conserved despite mutations. The newly emerged variants show changes in glycosylation patterns that may be related to their infectivity.

SCIENTIFIC REPORTS (2023)

Article Chemistry, Multidisciplinary

O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Likely Contribute to the Mutational Trajectory in Variants of Concern

Edgar Gonzalez-Rodriguez et al.

Summary: The polybasic cleavage motif for the protease furin is a major factor in human viral transmission of SARS-CoV-2 spike. Variants of concern (VOCs) have extensive mutations in the region preceding this motif. Besides furin, spikes from these variants rely on other proteases such as TMPRSS2 for maturation. Glycans near the cleavage site have implications for proteolytic processing and the effects of variant-borne mutations.

ACS CENTRAL SCIENCE (2023)

Article Biochemistry & Molecular Biology

Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants

Yongjing Xie et al.

Summary: This study quantitatively investigated the N-glycosylation profiles of seven major emerging spike variants and found significant differences among them, which can be used for classification of different variants.

GLYCOBIOLOGY (2023)

Article Chemistry, Analytical

A Broad-Specificity O-Glycoprotease That Enables Improved Analysis of Glycoproteins and Glycopeptides Containing Intact Complex O-Glycans

Saulius Vainauskas et al.

Summary: Characterizing mucin-type O-glycans linked to serine/threonine of glycoproteins is challenging due to limited enzymatic tools. This study demonstrated the effectiveness of the immunomodulating metalloprotease IMPa from Pseudomonas aeruginosa in cleaving peptides and proteins with various O-glycans, enabling comprehensive analysis without glycopeptide enrichment.

ANALYTICAL CHEMISTRY (2022)

Article Virology

Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa

Lulan Wang et al.

Summary: The discovery of the Omicron variant has sparked global concerns about its mutations, transmission, and immune escape properties. Current research suggests that the variant may impact viral infectivity and host immunity, and it may evolve from clade 20B.

JOURNAL OF MEDICAL VIROLOGY (2022)

Article Medicine, General & Internal

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

Nicole Wolter et al.

Summary: According to data analysis from South Africa, individuals infected with the omicron variant have a lower likelihood of hospitalization compared to those infected with non-omicron variants. Furthermore, individuals infected with the omicron variant have a lower odds of severe disease compared to individuals infected with the earlier delta variant.

LANCET (2022)

Article Multidisciplinary Sciences

Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core

Alexander J. Pak et al.

Summary: Simulations reveal that the interaction between SARS-CoV-2 spike trimers and ACE2 receptors is cooperative, resulting in spike binding and shedding. The simulations also suggest that the efficacy of variants is enhanced by increased RBD opening or S1/S2 cleavage efficiency. This study provides important insights into the molecular mechanism of viral entry and has implications for therapeutic interventions.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Principles of SARS-CoV-2 glycosylation

Himanshi Chawla et al.

Summary: Research has shown that the structure and post-translational processing of the SARS-CoV-2 spike glycoprotein are closely associated with the function of the virus and the efficacy of sterilizing vaccines. The study suggests that glycans play an important role in the immunogen structure and efficacy.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2022)

Article Multidisciplinary Sciences

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

Matthew McCallum et al.

Summary: The SARS-CoV-2 Omicron variant evades antibody-mediated immunity and exhibits enhanced affinity for host cells due to accumulation of spike mutations and remodeling of interactions with the ACE2 receptor.

SCIENCE (2022)

Review Virology

How Do Point Mutations Enhancing the Basic Character of the RBDs of SARS-CoV-2 Variants Affect Their Transmissibility and Infectivity Capacities?

Annick Barre et al.

Summary: The spread of SARS-CoV-2 variants depends on the interaction between the electropositive spike protein RBD and the electronegative ACE2 receptor. Point mutations that increase electropositive residues, such as arginine and lysine, in the RBD of spike proteins can enhance recognition by the electronegative ACE2 receptors and contribute to the spreading capacity of the variants. Highly transmissible variants like kappa, delta, and omicron have an enhanced electropositive character in their RBDs due to a higher number of lysine or arginine-generating point mutations.

VIRUSES-BASEL (2022)

Article Multidisciplinary Sciences

Evolution of the SARS-CoV-2 spike protein in the human host

Antoni G. Wrobel et al.

Summary: Recently emerged variants of SARS-CoV-2, such as Alpha and Beta, have spike glycoproteins with multiple substitutions that increase transmission and resistance to neutralizing antibodies. The spike proteins of these variants have acquired mutations that affect receptor binding and stability upon binding. This research provides insights into the evolution of the virus and its ability to transmit in humans.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant

Yang Liu et al.

Summary: This study reports that the P681R mutation in the Delta spike plays a crucial role in the replacement of the Alpha variant by the Delta variant during the COVID-19 pandemic. The Delta variant outcompetes the Alpha variant in human lung cells and airway tissues. The P681R mutation enhances the cleavage of the spike protein, leading to increased replication of the Delta variant.

CELL REPORTS (2022)

Article Chemistry, Multidisciplinary

Comparative N-Glycoproteomics Analysis of Clinical Samples Via Different Mass Spectrometry Dissociation Methods

Wenjuan Zeng et al.

Summary: “Site-specific N-glycosylation characterization requires intact N-glycopeptide analysis based on suitable tandem mass spectrometry methods. Various approaches, including EThcD, sceHCD, HCD-pd-ETD, and EThcD-sceHCD, have been developed for glycoprotein analysis, each with its own strengths and compromises. Comparative analysis showed that EThcD-sceHCD performed well in identifying intact N-glycopeptides with depth and accuracy, holding great potential for biomarker discovery in clinical samples.”

FRONTIERS IN CHEMISTRY (2022)

Article Biology

Insights into the structural peculiarities of the N-terminal and receptor binding domains of the spike protein from the SARS-CoV-2 Omicron variant

Fatemeh Bayani et al.

Summary: This study investigated the impact of mutations in the NTD and RBD domains of the spike protein on the development of COVID-19 vaccines using computational analysis. The results showed that long glycans can reduce the accessibility of protein epitopes, thereby affecting the binding efficiency and neutralizing potency of specific antibodies. Additionally, the presence of long glycans enhanced the stability and affinity of the RBD to ACE2. The study also identified key residues that play a role in increasing the structural stability of the protein. These findings contribute to a better understanding of the structural changes in the spike protein and have implications for the development of novel therapeutics.

COMPUTERS IN BIOLOGY AND MEDICINE (2022)

Article Virology

Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment

Suresh Kumar et al.

Summary: This study used computational tools to evaluate the infectivity, transmission, and pathogenicity of the Omicron variant and its sub-variants. The research found that the Omicron and sub-variants have multiple mutations in the receptor-binding domain, increasing their affinity for human ACE2 and potential for transmission. However, mutations in the spike protein's N-terminal domain may result in less impact on the lower respiratory tract. Some mutations in the sub-variants of Omicron seemed to restore the binding effectiveness to ACE2.

JOURNAL OF MEDICAL VIROLOGY (2022)

Review Biochemical Research Methods

Site-specific glycosylation of SARS-CoV-2: Big challenges in mass spectrometry analysis

Diana Campos et al.

Summary: Glycosylation is essential for the formation and infectivity of viruses, and distinct glycans also play crucial roles in evading the host's immune system. Recent advancements in viral glycosylation analysis, particularly of spike proteins, have been achieved using mass spectrometry methodologies. However, there are still challenges in determining the site-specific glycosylation of SARS-CoV-2 viral spike protein. This review provides a comprehensive understanding of spike protein glycosylation and emphasizes the importance of consistent glycosylation determination.

PROTEOMICS (2022)

Article Chemistry, Analytical

Systematic analysis and comparison of O-glycosylation of five recombinant spike proteins in 8-coronaviruses

Xuefang Dong et al.

Summary: This study comprehensively characterized O-glycosylation of 8-CoVs S1 proteins and revealed the heterogeneity. Differences in O-glycosylation between SARS-CoV-2 and its D614G mutant on functional domains were also identified. This work is of great significance for guiding the development of related vaccines and antiviral drugs.

ANALYTICA CHIMICA ACTA (2022)

Review Pharmacology & Pharmacy

Glycosylation in SARS-CoV-2 variants: A path to infection and recovery

Arya Aloor et al.

Summary: Glycans play a crucial role in controlling and driving life, especially in the context of COVID-19 infection. Despite the development of vaccines, the impact of mutant variations on immunity is still uncertain. This paper discusses the role of glycosylation in viral entry, infection, antigen presentation, and immune responses.

BIOCHEMICAL PHARMACOLOGY (2022)

Article Microbiology

Characterization and Function of Glycans on the Spike Proteins of SARS-CoV-2 Variants of Concern

Luping Zheng et al.

Summary: This study investigates the glycosylation patterns of different variants of the SARS-CoV-2 spike protein and their implications for infectivity and immunogenicity. The Omicron variant shows differential expression of glycans, which affect its binding ability and sensitivity to neutralizing antibodies. These findings contribute to our understanding of SARS-CoV-2 infection mechanisms and provide potential targets for therapeutic interventions and vaccine development.

MICROBIOLOGY SPECTRUM (2022)

Article Biochemical Research Methods

Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins

Yong Zhang et al.

Summary: This study characterized the N-glycosylation of the S protein of SARS-CoV-2, revealing differences in glycan type and abundance between human and insect cell-expressed proteins. These findings shed light on the infection mechanism and offer new perspectives for the development of vaccines and targeted drugs.

MOLECULAR & CELLULAR PROTEOMICS (2021)

Article Chemistry, Analytical

N- and O-Glycosylation of the SARS-CoV-2 Spike Protein

Miloslav Sanda et al.

Summary: The outbreak of the Covid-19 pandemic has caused the current global health crisis, prompting the need for detailed studies on SARS-CoV-2 proteins to develop effective antiviral compounds and vaccines. The glycosylation of the spike (S) protein plays a significant role in its proteolytic activation, expanding the current knowledge in this area.

ANALYTICAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Erik Volz et al.

Summary: The study suggests a positive selection for the SARS-CoV-2 spike protein variant D614G in the UK, but no evidence of differences in COVID-19 mortality or clinical severity in patients infected with this variant. 614G is associated with higher viral load and younger age of patients compared to 614D.
Article Multidisciplinary Sciences

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Tyler N. Starr et al.

Summary: Research has found that mutations in the receptor binding domain (RBD) of SARS-CoV-2 may potentially escape the action of the REGN-COV2 cocktail, providing important information for interpreting mutations observed during viral surveillance.

SCIENCE (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

Jing-Hui Tian et al.

Summary: The study reports the development of a SARS-CoV-2 subunit vaccine candidate that contains full-length spike protein stabilized in its prefusion conformation, showing immunogenicity in mice and protection in baboons with Matrix-M adjuvanted vaccine, supporting ongoing phase 1/2 clinical evaluation of NVX-CoV2373 with Matrix-M (NCT04368988).

NATURE COMMUNICATIONS (2021)

Article Public, Environmental & Occupational Health

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021

Summer E. Galloway et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Biochemistry & Molecular Biology

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

Emma C. Thomson et al.

Summary: SARS-CoV-2 virus can mutate and evade immunity, with mutations like N439K conferring resistance against neutralizing monoclonal antibodies and enhancing binding affinity to hACE2 receptor. Despite similar in vitro replication fitness and clinical outcomes compared to wild type, N439K mutation highlights the importance of ongoing molecular surveillance for guiding vaccine and therapeutic development and usage.
Article Multidisciplinary Sciences

Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation

Liping Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Multidisciplinary Sciences

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Pengfei Wang et al.

Summary: The COVID-19 pandemic has had global repercussions, with promising vaccines and monoclonal antibody therapies. However, newly detected variants of SARS-CoV-2 present challenges to these treatment options.

NATURE (2021)

Article Biochemistry & Molecular Biology

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Rita E. Chen et al.

Summary: The study analyzed antibody neutralization activity against a panel of authentic isolates and chimeric SARS-CoV-2 variants, showing significantly reduced neutralizing activity against the B.1.351 variant first identified in South Africa. Antibodies targeting the receptor-binding domain and N-terminal domain, monoclonal antibodies, convalescent sera, and mRNA vaccine-induced immune sera exhibited decreased inhibitory activity against viruses with an E484K spike mutation, suggesting a need for updated monoclonal antibodies or vaccine adjustments to prevent loss of protection against emerging variants.

NATURE MEDICINE (2021)

Article Microbiology

A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants

Denise Haslwanter et al.

Summary: The study identified a panel of potent RBD and NTD nAbs against SARS-CoV-2, with the most potent RBD nAb targeting a residue at F490 and the most potent NTD nAb epitope including Y145, K150, and W152. Combining RBD and NTD nAbs did not enhance neutralization potential but limited the development of neutralization-escape mutants in vitro, suggesting a potential strategy to mitigate the emergence of VOC.
Article Microbiology

Global Diversification and Distribution of Coronaviruses With Furin Cleavage Sites

Xiaotong Liu et al.

Summary: This study examines the global epidemiology and evolutionary history of coronaviruses with furin cleavage sites, revealing their widespread distribution in various animal hosts and regions. In addition, the discovery of at least five coronaviruses capable of infecting humans, with two of them having furin cleavage sites, sheds light on their transmission and evolution.

FRONTIERS IN MICROBIOLOGY (2021)

Letter Cell Biology

The basis of a more contagious 501Y.V1 variant of SARS-CoV-2

Haolin Liu et al.

CELL RESEARCH (2021)

Article Immunology

Sequential Analysis of the N/O-Glycosylation of Heavily Glycosylated HIV-1 gp120 Using EThcD-sceHCD-MS/MS

Yong Zhang et al.

Summary: This study presents a hybrid dissociation technique for analyzing the glycosylation of highly glycosylated proteins, improving the performance of N/O-glycosylation analysis of the HIV-1 Env protein gp120. The method identified more glycopeptides and produced more comprehensive fragment ions for accurate glycosite assignment, demonstrating the potential for understanding HIV-1 infection and developing vaccines and drugs.

FRONTIERS IN IMMUNOLOGY (2021)

Article Chemistry, Multidisciplinary

Site-Specific Glycosylation Patterns of the SARS-CoV-2 Spike Protein Derived From Recombinant Protein and Viral WA1 and D614G Strains

Yuan Tian et al.

Summary: The study characterized the glycosylation patterns of the SARS-CoV-2 spike protein and found differences in glycosylation profiles among proteins derived from different cell sources. This suggests that the choice of cell substrate for protein production can impact host-pathogen interactions mediated by spike glycans.

FRONTIERS IN CHEMISTRY (2021)

Article Virology

Within-Host and Between-Host Evolution in SARS-CoV-2-New Variant's Source

Karin Moelling

Summary: Some newly emerging corona viral variants with high mutation rates have been found in immune compromised patients, showing potential to be sources of new variants with pandemic potential. Immunosuppressed patients may escape detection, highlighting the need for healthcare workers' attention and treatment.

VIRUSES-BASEL (2021)

Review Biochemical Research Methods

Glycosylation of SARS-CoV-2: structural and functional insights

Asif Shajahan et al.

Summary: The COVID-19 pandemic is caused by the SARS-CoV-2 virus, which contains glycosylated proteins that interact with host receptors like hACE2 to facilitate infection. Studies show that these glycosylated proteins play important roles in viral infection and immune evasion, understanding which can aid in developing suitable prevention and therapy strategies.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2021)

Article Chemistry, Analytical

Systematic Evaluation of Fragmentation Methods for Unlabeled and Isobaric Mass Tag-Labeled O-Glycopeptides

Yang Mao et al.

Summary: Comparison of different dissociation methods for O-glycopeptides showed that ETciD and EThcD outperformed HCD in terms of glycopeptide identification and site localization. Additionally, a pseudo-EThcD strategy combining electron transfer dissociation with paired HCD spectra demonstrated improvements in identification and quantification of isobaric mass tag-labeled O-glycopeptides, leading to the discovery of specific glycosites of GALNT11 in HepG2 cells.

ANALYTICAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells

Luping Zheng et al.

Summary: The N-glycosylation of SARS-CoV-2 RBD is crucial for viral internalization and shielding the virus from neutralization. Deglycosylation reduces RBD binding to ACE2, while mutations at N-glycosites interfere with viral internalization and increase sensitivity to neutralizing antibodies.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Review Immunology

Neutralizing antibodies for the prevention and treatment of COVID-19

Lanying Du et al.

Summary: This review summarizes the neutralizing monoclonal antibodies targeting SARS-CoV-2 proteins developed to date, with a focus on the N-terminal domain and RBD of the S protein. The roles of binding affinity, neutralizing activity, and protection provided by these nAbs in the prevention and treatment of COVID-19 are discussed, as well as the potential to improve nAb efficiency against multiple SARS-CoV-2 variants.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Review Genetics & Heredity

Glycosylation is a key in SARS-CoV-2 infection

Celso A. Reis et al.

Summary: This study focuses on how glycosylation of both SARS-CoV-2 and target cells critically impacts infection at different levels, including virus binding and entry to host cells, immune response, and therapy and vaccination. It emphasizes the importance of considering glycans in tackling the disease, particularly in vaccine development, therapeutic strategies, and serological testing.

JOURNAL OF MOLECULAR MEDICINE-JMM (2021)

Article Biochemical Research Methods

Direct Comparison of N-Glycans and Their Isomers Derived from Spike Glycoprotein 1 of MERS-CoV, SARS-CoV-1, and SARS-CoV-2

Byeong Gwan Cho et al.

Summary: This study delves into the unexplored area of isomeric glycan distribution in the S1 protein of coronaviruses. By utilizing liquid chromatography coupled to tandem mass spectrometry, researchers aim to provide data support for future investigations on the role of isomeric glycans in coronavirus viral pathogenesis.

JOURNAL OF PROTEOME RESEARCH (2021)

Review Genetics & Heredity

The biological and clinical significance of emerging SARS-CoV-2 variants

Kaiming Tao et al.

Summary: The emergence of multiple SARS-CoV-2 variants has significant impacts on the epidemiological and clinical aspects of the COVID-19 pandemic, including increased virus transmission rates, heightened risk of reinfection, and reduced effectiveness of neutralizing antibodies and vaccines. These variants have introduced new challenges to COVID-19 research, necessitating additional avenues of laboratory, epidemiological, and clinical studies.

NATURE REVIEWS GENETICS (2021)

Review Microbiology

SARS-CoV-2 variants, spike mutations and immune escape

William T. Harvey et al.

Summary: The evolution of SARS-CoV-2 has been characterized by the emergence of mutations and variants that impact virus characteristics. Manufacturers are preparing for possible updates to vaccines in response to changes in the virus population, and it is crucial to monitor genetic and antigenic changes alongside experiments to understand the impacts of mutations.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Chemistry, Multidisciplinary

O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins

Yong Zhang et al.

Summary: The study revealed that the SARS-CoV-2 S protein is an O-glycoprotein, and the O-glycosylation landscapes vary with the host cell type.

FRONTIERS IN CHEMISTRY (2021)

Article Chemistry, Multidisciplinary

Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein

Yan Wang et al.

Summary: Research has shown that the glycosylation of the spike glycoprotein can vary significantly depending on the expression cell system, impacting its interaction with host cell receptors. It is crucial to carefully select the expression system when developing inhibitors, antibodies, and vaccines.

ACS OMEGA (2021)

Article Multidisciplinary Sciences

Cryo-EM analysis of a feline coronavirus spike protein reveals a unique structure and camouflaging glycans

Tzu-Jing Yang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

Article Multidisciplinary Sciences

Site-specific glycan analysis of the SARS-CoV-2 spike

Yasunori Watanabe et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation

Yasunori Watanabe et al.

NATURE COMMUNICATIONS (2020)

Letter Medicine, General & Internal

SARS-CoV-2 shedding and infectivity Reply

Fei Zhou et al.

LANCET (2020)

Article Biochemistry & Molecular Biology

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Markus Hoffmann et al.

MOLECULAR CELL (2020)

Article Multidisciplinary Sciences

Structural basis of receptor recognition by SARS-CoV-2

Jian Shang et al.

NATURE (2020)

Article Chemistry, Analytical

Molecular Diagnosis of COVID-19: Challenges and Research Needs

Wei Feng et al.

ANALYTICAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

The protein expression profile of ACE2 in human tissues

Feria Hikmet et al.

MOLECULAR SYSTEMS BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

Leonid Yurkovetskiy et al.

Article Multidisciplinary Sciences

Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion

Donald J. Benton et al.

NATURE (2020)

Article Biochemical Research Methods

O-Pair Search with MetaMorpheus for O-glycopeptide characterization

Lei Lu et al.

NATURE METHODS (2020)

Article Multidisciplinary Sciences

Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition

Oliver C. Grant et al.

SCIENTIFIC REPORTS (2020)

Review Medicine, General & Internal

Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2

Francesca Salamanna et al.

FRONTIERS IN MEDICINE (2020)

Article Biochemistry & Molecular Biology

Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2

Asif Shajahan et al.

GLYCOBIOLOGY (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

Yixuan J. Hou et al.

SCIENCE (2020)

Article Virology

Virus recognition of glycan receptors

Andrew J. Thompson et al.

CURRENT OPINION IN VIROLOGY (2019)

Article Multidisciplinary Sciences

Structure of the Lassa virus glycan shield provides a model for immunological resistance

Yasunori Watanabe et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

Global site-specific N-glycosylation analysis of HIV envelope glycoprotein

Liwei Cao et al.

NATURE COMMUNICATIONS (2017)

Review Virology

Viral O-GalNAc peptide epitopes: a novel potential target in viral envelope glycoproteins

Sigvard Olofsson et al.

REVIEWS IN MEDICAL VIROLOGY (2016)

Article Multidisciplinary Sciences

Pre-fusion structure of a human coronavirus spike protein

Robert N. Kirchdoerfer et al.

NATURE (2016)

Article Biochemistry & Molecular Biology

Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy

Alexandra C. Walls et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy

Alexandra C. Walls et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)

Review Microbiology

The sweet spot: defining virus-sialic acid interactions

Jennifer E. Stencel-Baerenwald et al.

NATURE REVIEWS MICROBIOLOGY (2014)

Review Biochemistry & Molecular Biology

Mucin-type O-glycans and their roles in intestinal homeostasis

Kirk S. B. Bergstrom et al.

GLYCOBIOLOGY (2013)

Article Biochemistry & Molecular Biology

The GlycanBuilder and GlycoWorkbench glycoinformatics tools: updates and new developments

David Damerell et al.

BIOLOGICAL CHEMISTRY (2012)